title: Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital and Department of Haematology, Belfast City Hospital, Belfast, UK. savageeimear@gmail.com.
authors.forename: Eimear
authors.initials: E
authors.lastname: Savage
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital and Department of Haematology, Belfast City Hospital, Belfast, UK.
authors.forename: Tasheen
authors.initials: T
authors.lastname: Wazir
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital and Department of Haematology, Belfast City Hospital, Belfast, UK.
authors.forename: Mary
authors.initials: M
authors.lastname: Drake
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital and Department of Haematology, Belfast City Hospital, Belfast, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Cuthbert
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital and Department of Haematology, Belfast City Hospital, Belfast, UK.
authors.forename: Gary
authors.initials: G
authors.lastname: Wright
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D055501:Macrophage Activation Syndrome / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D009205:Myocarditis / Q000188:drug therapy* / Q000209:etiology*; D016706:Still's Disease, Adult-Onset / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab